New Pharmaceutical Treatment of Gastric MALT Lymphoma: Anti-angiogenesis Treatment using VEGF Receptor Antibodies and Celecoxib

In addition to eradication of Helicobacter pylori, chemotherapy with anticancer agents, and radiation therapy, the treatment with molecular target drugs including rituximab, a CD20 antagonist, is one of the promising new regimens. The mucosa-associated lymphoid tissue (MALT) lymphoma is histological...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Curr Pharm Des
Asıl Yazarlar: Nakamura, Masahiko, Takahashi, Tetsufumi, Matsui, Hidenori, Takahashi, Shinichi, Murayama, Somay Y, Suzuki, Hidekazu, Tsuchimoto, Kanji
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Bentham Science Publishers 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4260359/
https://ncbi.nlm.nih.gov/pubmed/23782142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/13816128113199990420
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller